Two notable options have emerged: Genio Nyxoah and Inspire ... in sleep apnea treatment. The National Health Service (NHS) in the UK has already begun performing the first procedures, although ...

For treatment resistant cases a surgical device called Inspire (hypoglossal nerve ... Uvulopalatopharyngoplasty (UPPP) is the main surgery for sleep apnea. It removes the tonsils and tissue ...

The surgery, which takes roughly 30 ... he's largely back to living his life the way it was before sleep apnea derailed it. Since he received the Inspire implant, he's gone to grandkids' baseball ...

Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

(NYSE:INSP) in its Q3 2024 investor letter: "Inspire Medical Systems, Inc. (NYSE:INSP) also contributed. The company develops minimally invasive solutions for patients with obstructive sleep apnea ...

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

(NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea ...

30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive ...